[S-23] New fronteer of epileptogenicity: translatability between basic and clinical fields

[S-23-1] てんかん原生型アストロサイト

^○小泉 修一¹, 佐野 史和² (1.山梨大学　大学院総合研究部　医学域　薬理学, 2.山梨大学　大学院総合研究部　医学域　小児科)

Resume
2007-present: Prof, Dept Neuropharmacol, Interdiscip Grad Sch Med, Univ Yamanashi, Japan
1999-2006: Lab Chief, Ntl Inst Hlt Sci, Tokyo, Japan
1996-1998: Posdoc, Univ Cambridge, Cambridge, UK
1995: Researcher, Ntl Inst Hlt Sci, Tokyo, Japan
1992-1995: Posdoc, Human Health Science Foundation, Tokyo, Japan
1992: Ph.D., Kyushu Univ, Fukuoka, Japan
1989: M.A., Kyushu Univ, Fukuoka, Japan
1987: B.S., Kyushu Univ, Fukuoka, Japan

Representative publications
1. Morizawa et al., Nat Commun, 8, 28 (2017)
2. Miyamoto et al., Nat Commun, 7, 12540 (2016)
3. Shinozaki et al., Cell Rep, 19, 1151-1164 (2016)
4. Kim et al., J. Clin. Invest, 126, 1983-1997 (2016)
5. Hirayama et al., J Neurosci, 35, 5794-3805 (2015)
6. Koizumi et al., Nature, 446, 1091-1095 (2007).

Awards
2009 Japan Academy Medal
2009 Japan Society for the Promotion Science Prize
2003 First Prize for Young Researchers of Japanese Society for Neurochemistry.